These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 29773016)

  • 1. Is Cannabidiol a Promising Substance for New Drug Development? A Review of its Potential Therapeutic Applications.
    Noreen N; Muhammad F; Akhtar B; Azam F; Anwar MI
    Crit Rev Eukaryot Gene Expr; 2018; 28(1):73-86. PubMed ID: 29773016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD).
    Peng J; Fan M; An C; Ni F; Huang W; Luo J
    Basic Clin Pharmacol Toxicol; 2022 Apr; 130(4):439-456. PubMed ID: 35083862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings.
    Elsaid S; Kloiber S; Le Foll B
    Prog Mol Biol Transl Sci; 2019; 167():25-75. PubMed ID: 31601406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol.
    Romano B; Borrelli F; Pagano E; Cascio MG; Pertwee RG; Izzo AA
    Phytomedicine; 2014 Apr; 21(5):631-9. PubMed ID: 24373545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system.
    Campos AC; Ortega Z; Palazuelos J; Fogaça MV; Aguiar DC; Díaz-Alonso J; Ortega-Gutiérrez S; Vázquez-Villa H; Moreira FA; Guzmán M; Galve-Roperh I; Guimarães FS
    Int J Neuropsychopharmacol; 2013 Jul; 16(6):1407-19. PubMed ID: 23298518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scientific Validation of Cannabidiol for Management of Dog and Cat Diseases.
    Corsato Alvarenga I; Panickar KS; Hess H; McGrath S
    Annu Rev Anim Biosci; 2023 Feb; 11():227-246. PubMed ID: 36790884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer's disease.
    Li H; Liu Y; Tian D; Tian L; Ju X; Qi L; Wang Y; Liang C
    Eur J Med Chem; 2020 Apr; 192():112163. PubMed ID: 32109623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?
    Zlebnik NE; Cheer JF
    Annu Rev Neurosci; 2016 Jul; 39():1-17. PubMed ID: 27023732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age.
    Crippa JA; Guimarães FS; Campos AC; Zuardi AW
    Front Immunol; 2018; 9():2009. PubMed ID: 30298064
    [No Abstract]   [Full Text] [Related]  

  • 10. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.
    Malfait AM; Gallily R; Sumariwalla PF; Malik AS; Andreakos E; Mechoulam R; Feldmann M
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9561-6. PubMed ID: 10920191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling.
    Fogaça MV; Campos AC; Coelho LD; Duman RS; Guimarães FS
    Neuropharmacology; 2018 Jun; 135():22-33. PubMed ID: 29510186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and side effects of cannabidiol, a Cannabis sativa constituent.
    Bergamaschi MM; Queiroz RH; Zuardi AW; Crippa JA
    Curr Drug Saf; 2011 Sep; 6(4):237-49. PubMed ID: 22129319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic Strategies for (-)-Cannabidiol and Its Structural Analogs.
    Jung B; Lee JK; Kim J; Kang EK; Han SY; Lee HY; Choi IS
    Chem Asian J; 2019 Nov; 14(21):3749-3762. PubMed ID: 31529613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabidiol: State of the art and new challenges for therapeutic applications.
    Pisanti S; Malfitano AM; Ciaglia E; Lamberti A; Ranieri R; Cuomo G; Abate M; Faggiana G; Proto MC; Fiore D; Laezza C; Bifulco M
    Pharmacol Ther; 2017 Jul; 175():133-150. PubMed ID: 28232276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents.
    Fasinu PS; Phillips S; ElSohly MA; Walker LA
    Pharmacotherapy; 2016 Jul; 36(7):781-96. PubMed ID: 27285147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.
    Zuardi AW; Crippa JA; Hallak JE; Moreira FA; Guimarães FS
    Braz J Med Biol Res; 2006 Apr; 39(4):421-9. PubMed ID: 16612464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug.
    Schier AR; Ribeiro NP; Silva AC; Hallak JE; Crippa JA; Nardi AE; Zuardi AW
    Braz J Psychiatry; 2012 Jun; 34 Suppl 1():S104-10. PubMed ID: 22729452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological Aspects of Medical Use of Cannabidiol.
    Mannucci C; Navarra M; Calapai F; Spagnolo EV; Busardò FP; Cas RD; Ippolito FM; Calapai G
    CNS Neurol Disord Drug Targets; 2017; 16(5):541-553. PubMed ID: 28412918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action.
    Ożarowski M; Karpiński TM; Zielińska A; Souto EB; Wielgus K
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors.
    Espejo-Porras F; Fernández-Ruiz J; Pertwee RG; Mechoulam R; García C
    Neuropharmacology; 2013 Dec; 75():155-63. PubMed ID: 23924692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.